11/5/2021

Mineral Oil and Petrolatum Ophthalmic Ointment

Products Affected - Description

- Refresh Lacri-Lube PM, Allergan, 42.5%/56.8%, 7 g NDC 00023-0312-07 - discontinued

Reason for the Shortage

- Allergan has Refresh PM and Lacri-Lube SOP available. The Lacri-Lube SOP 7 gram tubes have been discontinued.
- Bausch Health has Soothe Night Time ointment available.
- Major has Lubrifresh PM ointment available.
- Alcon states the shortage was due to manufacturing issues and increased demand.

Available Products

- Genteal Tears Severe Nighttime Ointment, Alcon Labs, 3%/94%, 3.5 g Product 00065-0518-01
- Lubrifresh PM, Major, 15%/83%, 3.5 g NDC 00904-6488-38
- Refresh Lacri-Lube, Allergan, 42.5%/56.8%, 3.5 g NDC 00023-0312-04
- Refresh PM, Allergan, 42.5%/57.3%, 3.5 g NDC 00023-0240-04
- Soothe Night Time, Bausch Health, 20%/80%, 3.5 g NDC 10119-0223-99
- Systane Nighttime Ointment, Alcon Labs, 3%/94%, 3.5 g Product 00065-0509-35

Updated

Updated November 5, 2021 by Leslie Jensen, PharmD, Drug Information Specialist. Created June 6, 2018 by Anthony Trovato, PharmD, BCPS. © 2021, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.